miR‐152‐5p suppresses glioma progression and tumorigenesis and potentiates temozolomide sensitivity by targeting FBXL7
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
miR‐152‐5p suppresses glioma progression and tumorigenesis and potentiates temozolomide sensitivity by targeting FBXL7
Authors
Keywords
-
Journal
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
Volume 24, Issue 8, Pages 4569-4579
Publisher
Wiley
Online
2020-03-10
DOI
10.1111/jcmm.15114
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Temozolomide Induced Hypermutation in Glioma: Evolutionary Mechanisms and Therapeutic Opportunities
- (2019) Paul Daniel et al. Frontiers in Oncology
- Applications of molecular neuro-oncology - a review of diffuse glioma integrated diagnosis and emerging molecular entities
- (2019) Matthew D. Wood et al. Diagnostic Pathology
- Ependymal fluorescence in fluorescence-guided resection of malignant glioma: a systematic review
- (2019) Michael Müther et al. ACTA NEUROCHIRURGICA
- Sonodynamic Therapy for Gliomas. Perspectives and Prospects of Selective Sonosensitization of Glioma Cells
- (2019) Krzysztof Bilmin et al. Cells
- Ultrasound-Induced Blood-Brain-Barrier Opening Enhances Anticancer Efficacy in the Treatment of Glioblastoma: Current Status and Future Prospects
- (2019) Zhiting Deng et al. Journal of Oncology
- Prognostic and Clinic Pathological Value of Cx43 Expression in Glioma: A Meta-Analysis
- (2019) Chao Zhang et al. Frontiers in Oncology
- Mcl-1 phosphorylation without degradation mediates sensitivity to HDAC inhibitors by liberating BH3-only proteins
- (2018) Jingshan Tong et al. CANCER RESEARCH
- MiR-152-5p as a microRNA passenger strand special functions in human gastric cancer cells
- (2018) Wendao You et al. International Journal of Biological Sciences
- Involvement of Intracellular Cholesterol in Temozolomide-Induced Glioblastoma Cell Death
- (2018) Yutaro YAMAMOTO et al. NEUROLOGIA MEDICO-CHIRURGICA
- Regulation of microRNA biogenesis and its crosstalk with other cellular pathways
- (2018) Thomas Treiber et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Potential Strategies Overcoming the Temozolomide Resistance for Glioblastoma
- (2018) Shabierjiang JIAPAER et al. NEUROLOGIA MEDICO-CHIRURGICA
- FBW7 -Dependent Mcl-1 Degradation Mediates the Anticancer Effect of Hsp90 Inhibitors
- (2017) Jingshan Tong et al. MOLECULAR CANCER THERAPEUTICS
- Aurora kinase A regulates Survivin stability through targeting FBXL7 in gastric cancer drug resistance and prognosis
- (2017) M Kamran et al. Oncogenesis
- miR-152 as a tumor suppressor microRNA: Target recognition and regulation in cancer
- (2016) XUEXIANG LIU et al. Oncology Letters
- BRAFV600E-dependent Mcl-1 stabilization leads to everolimus resistance in colon cancer cells
- (2016) Kan He et al. Oncotarget
- A novel serum microRNA panel to discriminate benign from malignant ovarian disease
- (2015) Ream Langhe et al. CANCER LETTERS
- The Proapoptotic F-box Protein Fbxl7 Regulates Mitochondrial Function by Mediating the Ubiquitylation and Proteasomal Degradation of Survivin
- (2015) Yuan Liu et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- F-box protein Fbxl18 mediates polyubiquitylation and proteasomal degradation of the pro-apoptotic SCF subunit Fbxl7
- (2015) Y Liu et al. Cell Death & Disease
- MicroRNA-152-mediated dysregulation of hepatic transferrin receptor 1 in liver carcinogenesis
- (2015) Iryna Kindrat et al. Oncotarget
- The ubiquitin ligase FbxL7 regulates the Dachsous-Fat-Dachs system in Drosophila
- (2014) M. Rodrigues-Campos et al. DEVELOPMENT
- MCL-1 Degradation Mediated by JNK Activation via MEKK1/TAK1-MKK4 Contributes to Anticancer Activity of New Tubulin Inhibitor MT189
- (2014) W. Wang et al. MOLECULAR CANCER THERAPEUTICS
- The Drosophila F-box protein Fbxl7 binds to the protocadherin Fat and regulates Dachs localization and Hippo signaling
- (2014) Justin A Bosch et al. eLife
- Role of SKP1-CUL1-F-Box-Protein (SCF) E3 Ubiquitin Ligases in Skin Cancer
- (2013) Chuan-Ming Xie et al. Journal of Genetics and Genomics
- MiR-152 and miR-185 co-contribute to ovarian cancer cells cisplatin sensitivity by targeting DNMT1 directly: a novel epigenetic therapy independent of decitabine
- (2013) Y Xiang et al. ONCOGENE
- Novel E3 ligase component FBXL7 ubiquitinates and degrades Aurora A, causing mitotic arrest
- (2012) Tiffany A. Coon et al. CELL CYCLE
- A novel approach to overcome temozolomide resistance in glioma and melanoma: Inactivation of MGMT by gene therapy
- (2011) Guan Jiang et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- The SKP1-Cul1-F-box and Leucine-rich Repeat Protein 4 (SCF-FbxL4) Ubiquitin Ligase Regulates Lysine Demethylase 4A (KDM4A)/Jumonji Domain-containing 2A (JMJD2A) Protein
- (2011) Capucine Van Rechem et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Cullin-RING ubiquitin ligases: global regulation and activation cycles
- (2008) Dimple R Bosu et al. Cell Division
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation